FIELD: medicine. SUBSTANCE: claimed form is substantially free of any other physical forms, is crystalline and has powder X-ray pattern with characteristic maximums at 14.0, 19.0, 22.0, 22.4 and 24.7 °. Present invention describes methods of preparation of said form and pharmaceutical compositions containing it. The claimed compound is essentially agent which has antileucotriene activity and is useful for treating diseases such as asthma. EFFECT: improved properties of the pharmaceutical composition. 4 cl, 2 dwg, 1 tbl
| Title |
Year |
Author |
Number |
| METHOD FOR PRODUCTION OF 3-ALKYLATED INDOLE AND (2-NITROPHENYL)-ACETALDEHYDE |
1991 |
- Robert Toms Dzhehkobs[Gb]
- Dzherard Frehnsis Kostello[Gb]
- Stefen Alan Bruk[Gb]
- Piter Dzhon Kharrison[Gb]
|
RU2054417C1 |
| CRYSTALLINE FORM OF N-[4-[5(CYCLOPENTYLOXYCARBONYL)-AMINO-1-METHYL-INDOLE-3-YLMETHYL]-3- METHOXYBENZOYL]-2-METHYLBENZENE SULFONE AMIDE POSSESSING ACTIVITY AS ANTAGONIST OF LEUCOTRIENES |
1991 |
- Martin Pol Ehdvards[Gb]
- Dzhon Dehvid Shervud[Gb]
|
RU2107682C1 |
| PHARMACEUTICAL COMPOSITION, METHOD FOR ITS OBTAINING, PHYSICAL FORM OF N-;4-;5-(CYCLOPENTYLOXYCARBONYL)AMINO-1-METHILINDOL-3-IL-METHYL-3- -METHOXYBENZOIL |
1991 |
- Dzhejms Dzhozef Kholokhan[Gb]
- Ieuan Dzhon Ehdvrds[Gb]
- Robert Dzhozef Timko[Us]
- Rehndi Dzhon Brehdvehj[Us]
- Arlin Klements[Us]
|
RU2106140C1 |
| QUINAZOLINE DERIVATIVES, METHOD OF THEIR SYNTHESIS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF |
1993 |
- Stiven Dzhon Pegg[Gb]
- Dzhejms Majkl Vordlvert[Gb]
|
RU2111209C1 |
| DERIVATIVES OF QUINAZOLINE OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS AND A PHARMACEUTICAL COMPOSITION BASED ON SAID |
1993 |
|
RU2127263C1 |
| DERIVATIVES OF QUATERNARY AMINOPYRIMIDINE AND PHARMACEUTICAL COMPOSITION |
1990 |
- Rodni Brajan Khargrivs[Gb]
- Pol Vill'Jam Marshall[Gb]
- Bernard Dzhozef Makloglin[Gb]
- Stjuart Dennet Millz[Gb]
|
RU2108329C1 |
| 4-[2-(2-HYDROXY-2-PHENYLETHYLAMINO)ETHOXY]-PHENYLACETIC ACID OR ITS BIOPRECURSOR OR PHARMACEUTICALLY ACCEPTABLE SALT, METHOD OF ITS SYNTHESIS, COMPOSITION BASED ON THEREOF |
1992 |
- Brajan Roj Khollouehj[Gb]
- Ral'F Khouv[Gb]
- Val'Bir Singkh Rao[Gb]
|
RU2073666C1 |
| PIPERIDINYL-SUBSTITUTED METHANOANTHRACENES AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A PHARMACEUTICAL COMPOSITION BASED ON SAID AND METHODS OF THEIR SYNTHESIS |
1994 |
- Majkl Taddeus Klimas
- Mark Ornal Terpko
|
RU2128178C1 |
| N,N-DIMETHYL-2-(5-(2-OXO-1,3-OXAZOLIDINE-4-YL-METHYL)-1H-INDO- -LE-3-YL)-ETHYLAMINE, ITS PHYSIOLOGICALLY ACCEPTABLE SALT OR SOLVATE, METHOD OF ITS SYNTHESIS, DRUG USED AS AN AGONIST OF "5-HT-LIKE" RECEPTOR IN MAMMALS, METHOD OF DRUG AGENT PREPARING |
1991 |
- Alan Dunkan Robertson[Gb]
- Alan Piter Khill[Gb]
- Robert Cherl'Z Glen[Gb]
- Grehm Richard Martin[Gb]
|
RU2110517C1 |
| QUINAZOLINE DERIVATIVES, METHOD OF PREPARATION THEREOF, PHARMACEUTICAL COMPOSITION, AND A METHOD FOR REACHING ANTIPROLIFERATIVE EFFECTS |
1996 |
|
RU2153495C2 |
